HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease

Journal of Proteome Research

Volumn 12, Issue 7, 2013, Pages 3519-3528

  Tripathi, Pratima ^a   Somashekar, Bagganahalli S ^a   Ponnusamy, M ^c   Gursky, Amy ^b   Dailey, Stephen ^b   Kunju, Priya ^b   Lee, Cheryl T ^b   Chinnaiyan, Arul M ^a,b,c   Rajendiran, Thekkelnaycke M ^b,c   Ramamoorthy, Ayyalusamy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

bladder cancer; energy metabolism; GC MS; HR MAS NMR; metabolites; metabolomics

Indexed keywords

PROTON;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BLADDER CANCER; CLUSTER ANALYSIS; DISEASE MARKER; FEMALE; HIGH RESOLUTION MAGIC ANGLE SPINNING PROTON NUCLEAR MAGNETIC RESONANCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, GAS; DIAGNOSIS, DIFFERENTIAL; ENERGY METABOLISM; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84879904983     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr4004135     Document Type: Article

References (51)

1. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012 CA Cancer J. Clin. 2012, 62 (1) 10-29
2. Avritscher, E. B.; Cooksley, C. D.; Grossman, H. B.; Sabichi, A. L.; Hamblin, L.; Dinney, C. P.; Elting, L. S. Clinical model of lifetime cost of treating bladder cancer and associated complications Urology 2006, 68 (3) 549-53
3. Frantzi, M.; Makridakis, M.; Vlahou, A. Biomarkers for bladder cancer aggressiveness Curr. Opin. Urol. 2012, 22 (5) 390-6
4. Tomita, M.; Kami, K. Cancer. Systems biology, metabolomics, and cancer metabolism Science 2012, 336 (6084) 990-1
5. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009, 457 (7231) 910-4
6. Serkova, N. J.; Glunde, K. Metabolomics of cancer Methods Mol. Biol. 2009, 520, 273-95
7. Gowda, G. A.; Zhang, S.; Gu, H.; Asiago, V.; Shanaiah, N.; Raftery, D. Metabolomics-based methods for early disease diagnostics Expert Rev. Mol. Diagn. 2008, 8 (5) 617-33
8. Bathen, T. F.; Sitter, B.; Sjobakk, T. E.; Tessem, M. B.; Gribbestad, I. S. Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation Cancer Res. 2010, 70 (17) 6692-6
9. Beckonert, O.; Coen, M.; Keun, H. C.; Wang, Y.; Ebbels, T. M.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues Nat. Protoc. 2010, 5 (6) 1019-32
10. Somashekar, B. S.; Kamarajan, P.; Danciu, T.; Kapila, Y. L.; Chinnaiyan, A. M.; Rajendiran, T. M.; Ramamoorthy, A. Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues J. Proteome Res. 2011, 10 (11) 5232-41
11. Sitter, B.; Lundgren, S.; Bathen, T. F.; Halgunset, J.; Fjosne, H. E.; Gribbestad, I. S. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters NMR Biomed. 2006, 19 (1) 30-40
12. Bathen, T. F.; Jensen, L. R.; Sitter, B.; Fjosne, H. E.; Halgunset, J.; Axelson, D. E.; Gribbestad, I. S.; Lundgren, S. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status Breast Cancer Res. Treat. 2007, 104 (2) 181-9
13. Cheng, L. L.; Burns, M. A.; Taylor, J. L.; He, W.; Halpern, E. F.; McDougal, W. S.; Wu, C. L. Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy Cancer Res. 2005, 65 (8) 3030-4
14. Tessem, M. B.; Swanson, M. G.; Keshari, K. R.; Albers, M. J.; Joun, D.; Tabatabai, Z. L.; Simko, J. P.; Shinohara, K.; Nelson, S. J.; Vigneron, D. B.; Gribbestad, I. S.; Kurhanewicz, J. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues Magn. Reson. Med. 2008, 60 (3) 510-6
15. Chen, W.; Zu, Y.; Huang, Q.; Chen, F.; Wang, G.; Lan, W.; Bai, C.; Lu, S.; Yue, Y.; Deng, F. Study on metabonomic characteristics of human lung cancer using high resolution magic-angle spinning 1H NMR spectroscopy and multivariate data analysis Magn. Reson. Med. 2011, 66 (6) 1531-40
16. Rocha, C. M.; Barros, A. S.; Gil, A. M.; Goodfellow, B. J.; Humpfer, E.; Spraul, M.; Carreira, I. M.; Melo, J. B.; Bernardo, J.; Gomes, A.; Sousa, V.; Carvalho, L.; Duarte, I. F. Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy J. Proteome Res. 2010, 9 (1) 319-32
17. Chan, E. C.; Koh, P. K.; Mal, M.; Cheah, P. Y.; Eu, K. W.; Backshall, A.; Cavill, R.; Nicholson, J. K.; Keun, H. C. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS) J. Proteome Res. 2009, 8 (1) 352-61
18. Sitter, B.; Bathen, T.; Hagen, B.; Arentz, C.; Skjeldestad, F. E.; Gribbestad, I. S. Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy MAGMA 2004, 16 (4) 174-81
19. De Silva, S. S.; Payne, G. S.; Thomas, V.; Carter, P. G.; Ind, T. E.; deSouza, N. M. Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31)P magic angle spinning MRS of intact tissue NMR Biomed. 2009, 22 (2) 191-8
20. Yang, Y.; Li, C.; Nie, X.; Feng, X.; Chen, W.; Yue, Y.; Tang, H.; Deng, F. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis J. Proteome Res. 2007, 6 (7) 2605-14
21. Tugnoli, V.; Mucci, A.; Schenetti, L.; Righi, V.; Calabrese, C.; Fabbri, A.; Di Febo, G.; Tosi, M. R. Ex vivo HR-MAS Magnetic Resonance Spectroscopy of human gastric adenocarcinomas: a comparison with healthy gastric mucosa Oncol. Rep. 2006, 16 (3) 543-53
22. Tate, A. R.; Foxall, P. J.; Holmes, E.; Moka, D.; Spraul, M.; Nicholson, J. K.; Lindon, J. C. Distinction between normal and renal cell carcinoma kidney cortical biopsy samples using pattern recognition of (1)H magic angle spinning (MAS) NMR spectra NMR Biomed. 2000, 13 (2) 64-71
23. Righi, V.; Mucci, A.; Schenetti, L.; Tosi, M. R.; Grigioni, W. F.; Corti, B.; Bertaccini, A.; Franceschelli, A.; Sanguedolce, F.; Schiavina, R.; Martorana, G.; Tugnoli, V. Ex vivo HR-MAS magnetic resonance spectroscopy of normal and malignant human renal tissues Anticancer Res. 2007, 27 (5A) 3195-204
24. Pasikanti, K. K.; Esuvaranathan, K.; Ho, P. C.; Mahendran, R.; Kamaraj, R.; Wu, Q. H.; Chiong, E.; Chan, E. C. Noninvasive urinary metabonomic diagnosis of human bladder cancer J. Proteome Res. 2010, 9 (6) 2988-95
25. Issaq, H. J.; Nativ, O.; Waybright, T.; Luke, B.; Veenstra, T. D.; Issaq, E. J.; Kravstov, A.; Mullerad, M. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry J. Urol. 2008, 179 (6) 2422-6
26. Cao, M.; Zhao, L.; Chen, H.; Xue, W.; Lin, D. NMR-based metabolomic analysis of human bladder cancer Anal. Sci. 2012, 28 (5) 451-6
27. Putluri, N.; Shojaie, A.; Vasu, V. T.; Vareed, S. K.; Nalluri, S.; Putluri, V.; Thangjam, G. S.; Panzitt, K.; Tallman, C. T.; Butler, C.; Sana, T. R.; Fischer, S. M.; Sica, G.; Brat, D. J.; Shi, H.; Palapattu, G. S.; Lotan, Y.; Weizer, A. Z.; Terris, M. K.; Shariat, S. F.; Michailidis, G.; Sreekumar, A. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression Cancer Res. 2011, 71 (24) 7376-86
28. Epstein, J. I.; Amin, M. B.; Reuter, V. R.; Mostofi, F. K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee Am. J. Surg. Pathol. 1998, 22 (12) 1435-48
29. Kirkali, Z.; Chan, T.; Manoharan, M.; Algaba, F.; Busch, C.; Cheng, L.; Kiemeney, L.; Kriegmair, M.; Montironi, R.; Murphy, W. M.; Sesterhenn, I. A.; Tachibana, M.; Weider, J. Bladder cancer: epidemiology, staging and grading, and diagnosis Urology 2005, 66 (6 Suppl 1) 4-34
30. Somashekar, B. S.; Amin, A. G.; Tripathi, P.; MacKinnon, N.; Rithner, C. D.; Shanley, C. A.; Basaraba, R.; Henao-Tamayo, M.; Kato-Maeda, M.; Ramamoorthy, A.; Orme, I. M.; Ordway, D. J.; Chatterjee, D. Metabolomic signatures in guinea pigs infected with epidemic-associated W-Beijing strains of Mycobacterium tuberculosis J. Proteome Res. 2012, 11 (10) 4873-84
31. Wishart, D. S.; Knox, C.; Guo, A. C.; Eisner, R.; Young, N.; Gautam, B.; Hau, D. D.; Psychogios, N.; Dong, E.; Bouatra, S.; Mandal, R.; Sinelnikov, I.; Xia, J.; Jia, L.; Cruz, J. A.; Lim, E.; Sobsey, C. A.; Shrivastava, S.; Huang, P.; Liu, P.; Fang, L.; Peng, J.; Fradette, R.; Cheng, D.; Tzur, D.; Clements, M.; Lewis, A.; De Souza, A.; Zuniga, A.; Dawe, M.; Xiong, Y.; Clive, D.; Greiner, R.; Nazyrova, A.; Shaykhutdinov, R.; Li, L.; Vogel, H. J.; Forsythe, I. HMDB: a knowledgebase for the human metabolome Nucleic Acids Res. 2009, 37 (Database issue) D603-10
32. Markley, J. L.; Ulrich, E. L.; Berman, H. M.; Henrick, K.; Nakamura, H.; Akutsu, H. BioMagResBank (BMRB) as a partner in the Worldwide Protein Data Bank (wwPDB): new policies affecting biomolecular NMR depositions J. Biomol. NMR 2008, 40 (3) 153-5
33. Lotan, Y.; Roehrborn, C. G. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses Urology 2003, 61 (1) 109-18; discussion 118
34. Martinez-Bisbal, M. C.; Marti-Bonmati, L.; Piquer, J.; Revert, A.; Ferrer, P.; Llacer, J. L.; Piotto, M.; Assemat, O.; Celda, B. 1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas NMR Biomed. 2004, 17 (4) 191-205
35. Warburg, O. On respiratory impairment in cancer cells Science 1956, 124 (3215) 269-70
36. Hoskin, P. J.; Sibtain, A.; Daley, F. M.; Wilson, G. D. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON Br. J. Cancer 2003, 89 (7) 1290-7
37. Palit, V.; Phillips, R. M.; Puri, R.; Shah, T.; Bibby, M. C. Expression of HIF-1alpha and Glut-1 in human bladder cancer Oncol. Rep. 2005, 14 (4) 909-13
38. Yoshimoto, M.; Waki, A.; Yonekura, Y.; Sadato, N.; Murata, T.; Omata, N.; Takahashi, N.; Welch, M. J.; Fujibayashi, Y. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells Nucl. Med. Biol. 2001, 28 (2) 117-22
39. Tripathi, P.; Kamarajan, P.; Somashekar, B. S.; MacKinnon, N.; Chinnaiyan, A. M.; Kapila, Y. L.; Rajendiran, T. M.; Ramamoorthy, A. Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target Int. J. Biochem. Cell Biol. 2012, 44 (11) 1852-61
40. Dang, C. V. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle 2010, 9 (19) 3884-6
41. Aboagye, E. O.; Bhujwalla, Z. M. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells Cancer Res. 1999, 59 (1) 80-4
42. Mitra, A. P.; Cote, R. J. Molecular pathogenesis and diagnostics of bladder cancer Annu. Rev. Pathol. 2009, 4, 251-85
43. Cummings, B. S. Phospholipase A2 as targets for anti-cancer drugs Biochem. Pharmacol. 2007, 74 (7) 949-59
44. Pelicano, H.; Carney, D.; Huang, P. ROS stress in cancer cells and therapeutic implications Drug Resist. Updates 2004, 7 (2) 97-110
45. Meister, A.; Anderson, M. E. Glutathione Annu. Rev. Biochem. 1983, 52, 711-60
46. Pendyala, L.; Velagapudi, S.; Toth, K.; Zdanowicz, J.; Glaves, D.; Slocum, H.; Perez, R.; Huben, R.; Creaven, P. J.; Raghavan, D. Translational studies of glutathione in bladder cancer cell lines and human specimens Clin. Cancer Res. 1997, 3 (5) 793-8
47. Lambert, I. H. Regulation of the cellular content of the organic osmolyte taurine in mammalian cells Neurochem. Res. 2004, 29 (1) 27-63
48. El Agouza, I. M.; Eissa, S. S.; El Houseini, M. M.; El-Nashar, D. E.; Abd El Hameed, O. M. Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients Angiogenesis 2011, 14 (3) 321-30
49. Lodi, A.; Tiziani, S.; Khanim, F. L.; Drayson, M. T.; Gunther, U. L.; Bunce, C. M.; Viant, M. R. Hypoxia triggers major metabolic changes in AML cells without altering indomethacin-induced TCA cycle deregulation ACS Chem. Biol. 2011, 6 (2) 169-75
50. Srivastava, S.; Roy, R.; Singh, S.; Kumar, P.; Dalela, D.; Sankhwar, S. N.; Goel, A.; Sonkar, A. A. Taurine-a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by (1)H NMR spectroscopy Cancer Biomarkers 2010, 6 (1) 11-20
51. Das, S. K.; Eder, S.; Schauer, S.; Diwoky, C.; Temmel, H.; Guertl, B.; Gorkiewicz, G.; Tamilarasan, K. P.; Kumari, P.; Trauner, M.; Zimmermann, R.; Vesely, P.; Haemmerle, G.; Zechner, R.; Hoefler, G. Adipose triglyceride lipase contributes to cancer-associated cachexia Science 2011, 333 (6039) 233-8